P Grygier, K Pustelny, G Dubin, A Czarna - bioRxiv, 2022 - biorxiv.org
DYRK1B kinase recently emerged as a potential target in cancer, metabolic syndrome, and
nonalcoholic fatty liver disease, but the lack of structural information hinders the design of …